Appointments: Five Prime, Depomed, Gilead, Arix Bioscience and Corbus
Executive Summary
This week's roundup includes high-level appointments by Five Prime Therapeutics, Depomed and Gilead Sciences and board appointments by Verseon, Arix Bioscience, and Corbus Pharmaceuticals.